Retrospective study assessing antibody response after One and/or two doses of BNT162b2 anti- sars-cov-2 mRNA vaccine in patients treated by CAR T-cells therapy
Latest Information Update: 27 Jan 2022
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 27 Jan 2022 New trial record
- 14 Dec 2021 Results presented at the 63rd American Society of Hematology Annual Meeting and Exposition